Abstract:Background: To investigate the value of quantitative parameters related to static imaging and fast kinetics imaging of total-body (TB) 2-[F-18]-fluoro-2-deoxy-D-glucose (F-18-FDG) positron emission tomography/ computed tomography (PET/CT) in differentiating benign from malignant pulmonary lesions and squamous cell carcinoma (SCC) from adenocarcinoma (AC) and to analyze the correlation of each parameter with the Ki-67 index. Methods: A total of 108 patients with pulmonary lesions from July 2021 to May 2022 in the Henan Provincial People's Hospital, China, were consecutively recruited for TB F-18-FDG PET/ CT in this prospective study. Static imaging parameters maximum standardized uptake value (SUVmax) and fast kinetics imaging parameters transport constant (K-1), rate constants (k2), time delay (t(d)), and fractional blood volume (v(b)) were calculated and compared. The area under the receiver operating characteristic (ROC) curve (AUC), Delong test, Logistic regression analyses, and Pearson correlation were used to assess diagnostic efficacy, find independent predictors and analyse correlations respectively. Results: Malignant lesions had higher SUVmax and K-1 and lower v(b) than benign lesions, and SCC had higher SUVmax and K-1 and lower t(d) and v(b) than AC (all P<0.05). For the differentiation of benign and malignant lesions, SUVmax, K-1, and v(b) were independent predictors, and AUC (SUVmax + K-1 + v(b)) =0.909 (95% CI: 0.839-0.956), AUC (SUVmax) =0.883 (95% CI: 0.807-0.937), AUC (K-1) =0.810 (95% CI: 0.723-0.879), and AUC (v(b)) =0.746 (95% CI: 0.653-0.825), where AUC (SUVmax + K-1 + v(b)) was significantly different from AUC (K-1), AUC (v(b)) (Z=3.006, 3.965, all P<0.05). For the differentiation of SCC and AC, SUVmax, K-1, t(d), and v(b) were independent predictors, and AUC (SUVmax + K-1 + t(d) + v(b)) =0.946 (95% CI: 0.840-0.991), AUC (SUVmax) =0.818 (95% CI: 0.680-0.914), AUC (K-1) =0.770 (95% CI: 0.626-0.879), AUC (v(b)) =0.737 (95% CI: 0.5900.853), and AUC (t(d)) =0.669 (95% CI: 0.510-0.791), where AUC (SUVmax + K-1 + t(d) + v(b)) was significantly different from AUC (SUVmax), AUC (K-1), AUC (v(b)), and AUC (t(d)) (Z=2.269, 2.821, 2.848, and 3.276, all P<0.05). SUVmax and K-1 were moderately and mildly positively correlated with the Ki-67 index (r=0.541, 0.452, all P<0.05), respectively. Conclusions: Quantitative parameters of static imaging and fast kinetics imaging in F-18-FDG total-body PET/CT can be used to differentiate benign from malignant pulmonary lesions and SCC from AC and to assess Ki-67 expression.

Preliminary Study on Combining Bioconductance Measurement with 18FDG-PET in Evaluation CT Detected Lung Lesion Suspicious for Lung Cancer

P2.06-042 Evaluate the Utility of the Computed Bioconductance Measurement in the Diagnosis of Lung Cancer: Topic: LAB, Other

Integrated Strategy Combining Endobronchial Ultrasound with Positron Emission Tomography to Diagnose Peripheral Pulmonary Lesions.

Evaluation of lung lesions using FDG γ-camera PET equipped with a one-inch crystal

Application of 18F-FDG PET/CT Combined with High Resolution CT on Diagnosis of Lung Cancer

Pre-procedure 18 F-FDG PET/CT imaging improves the performance of CT-guided transthoracic biopsy

Improved Discrimination Between Benign and Malignant LDCT Screening-Detected Lung Nodules with Dynamic over Static 18F-FDG PET As a Function of Injected Dose

[18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects

The Value of 18F-FDG PET/CT Combined with Chest Thin-slice Breath-hold CT in the Diagnosis of Pulmonary Lesion

Diagnostic Value of Combination of PET/CT and Texture Features for Lung Cancer

Combination of circulating tumor cells and 18F‐FDG PET/CT for precision diagnosis in patients with non‐small cell lung cancer

18F-FDG PET/CT anatomic and metabolic guidance in CT-guided lung biopsies

The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma

18F-FDG Imaging by Coincidence Circuit SPECT with Low-Dose CT in Preoperative Assessment of Pulmonary Lesions

The clinical value of serum tumor markers combined PET/CT diagnosis on non-small cell lung cancer

Clinical value of 18F-FDG PET/CT in combination with mammography and ultrasound in diagnosis of breast cancer

Comparison Of Positron Emission Tomography Using 2-[F-18]-Fluoro-2-Deoxy-D-Glucose And 3-Deoxy-3-[F-18]-Fluorothymidine In Lung Cancer Imaging

P38.06 Evaluation of Non-invasive Transcutaneous Bioconductance Measurement - a Risk-Stratification Biomarker for Suspicious Pulmonary Lesions

Diagnostic Performance of 18F-FDG Positron Emission Tomography/Computed Tomography and Blood Test Parameters for Pulmonary Inflammatory Pseudotumor

[ 18 F]FDG PET/MRI Combined with Chest HRCT in Early Cancer Detection: a Retrospective Study of 3020 Asymptomatic Subjects

Quantitative parameters of static imaging and fast kinetics imaging in <SUP>18</SUP>F-FDG total-body PET/CT for the assessment of histological feature of pulmonary lesions